Cover Image
市場調查報告書

Kasiak Research Private Limited:產品平台分析

Kasiak Research Private Limited - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 341510
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Kasiak Research Private Limited:產品平台分析 Kasiak Research Private Limited - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 23 Pages
簡介

Kasiak Research Private Limited 是致力於再生醫療的解決方案中未滿足的醫療需求的研究開發型企業。該公司的產品系列中,人類間葉幹細胞,動物幹細胞,成長凝血因子濃縮劑。

本報告提供Kasiak Research Private Limited 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估及暫停中的計劃相關資訊等

Kasiak Research Private Limited的基本資料

  • Kasiak Research Private Limited概要
  • 主要資訊
  • 企業資料

Kasiak Research Private Limited:R&D概要

  • 主要的治療範圍

Kasiak Research Private Limited:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Kasiak Research Private Limited:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA 被申請的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式

Kasiak Research Private Limited:藥物簡介

Kasiak Research Private Limited:開發平台分析

  • 各給藥途徑
  • 各分子類型

Kasiak Research Private Limited:最近的開發平台趨勢

Kasiak Research Private Limited:暫停中的計劃

Kasiak Research Private Limited:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC07530CDB

Summary

Global Markets Direct's, 'Kasiak Research Private Limited - Product Pipeline Review - 2015', provides an overview of the Kasiak Research Private Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kasiak Research Private Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Kasiak Research Private Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Kasiak Research Private Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Kasiak Research Private Limited's pipeline products

Reasons to buy

  • Evaluate Kasiak Research Private Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Kasiak Research Private Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Kasiak Research Private Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Kasiak Research Private Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kasiak Research Private Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Kasiak Research Private Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Kasiak Research Private Limited Snapshot
    • Kasiak Research Private Limited Overview
    • Key Information
    • Key Facts
  • Kasiak Research Private Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Kasiak Research Private Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Kasiak Research Private Limited - Pipeline Products Glance
    • Kasiak Research Private Limited - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Kasiak Research Private Limited - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • Kasiak Research Private Limited - Drug Profiles
    • Refacell-CLI
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Refacell-IPF
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Idiopathic Pulmonary Fibrosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Refacell-DCM
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Refacell-T1D
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Kasiak Research Private Limited - Pipeline Analysis
    • Kasiak Research Private Limited - Pipeline Products by Route of Administration
    • Kasiak Research Private Limited - Pipeline Products by Molecule Type
  • Kasiak Research Private Limited - Recent Pipeline Updates
  • Kasiak Research Private Limited - Dormant Projects
  • Kasiak Research Private Limited - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Kasiak Research Private Limited, Key Information
  • Kasiak Research Private Limited, Key Facts
  • Kasiak Research Private Limited - Pipeline by Indication, 2015
  • Kasiak Research Private Limited - Pipeline by Stage of Development, 2015
  • Kasiak Research Private Limited - Monotherapy Products in Pipeline, 2015
  • Kasiak Research Private Limited - Phase I, 2015
  • Kasiak Research Private Limited - IND/CTA Filed, 2015
  • Kasiak Research Private Limited - Preclinical, 2015
  • Kasiak Research Private Limited - Pipeline by Route of Administration, 2015
  • Kasiak Research Private Limited - Pipeline by Molecule Type, 2015
  • Kasiak Research Private Limited - Recent Pipeline Updates, 2015
  • Kasiak Research Private Limited - Dormant Developmental Projects,2015
  • Kasiak Research Private Limited, Other Locations

List of Figures

  • Kasiak Research Private Limited - Pipeline by Top 10 Indication, 2015
  • Kasiak Research Private Limited - Pipeline by Stage of Development, 2015
  • Kasiak Research Private Limited - Monotherapy Products in Pipeline, 2015
  • Kasiak Research Private Limited - Pipeline by Top 10 Route of Administration, 2015
  • Kasiak Research Private Limited - Pipeline by Top 10 Molecule Type, 2015
Back to Top